MedPath

Temporal Variation in Exhaled Volatile Organic Compounds in Esophageal Cancer Patients

Not Applicable
Completed
Conditions
Esophageal Cancer
Registration Number
NCT06453993
Lead Sponsor
Benaroya Research Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Inclusion Criteria:<br><br> - Aged 18-90 years<br><br> - Newly-diagnosed, treatment naïve patients with esophageal and/or gastroesophageal<br> junctional cancer<br><br> - Planning to undergo curative treatment, including neoadjuvant chemoradiotherapy and<br> surgical resection<br><br>Exclusion Criteria:<br><br> - Pregnant females<br><br> - Without malignant esophageal disease<br><br> - Malignancy at a secondary site other than the esophagus<br><br> - Undergoing palliative treatment for esophageal cancer<br><br> - Not receiving neoadjuvant chemoradiotherapy and surgical resection for esophageal<br> cancer<br><br> - Inability or unwillingness to provide written informed consent

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Exhaled breath and urinary VOC concentrations as biomarkers of esophageal cancer
Secondary Outcome Measures
NameTimeMethod
Changes in VOC concentrations that occur in response to therapeutic intervention;Linkage of longitudinal VOC data to predominant upper gastrointestinal bacterial species;Patient acceptability of breath test
© Copyright 2025. All Rights Reserved by MedPath